TUESDAY, Jan. 8 (HealthDay News) -- More than a third of
American doctors say they sometimes or often write prescriptions
for pricier, brand-name drugs when a patient requests it, despite
the availability of cheaper and equally effective generic options,
a new national survey reveals.
The study also found that drug company marketing efforts might
play a role in the trend. Doctors who accepted small freebies, such
as free drug samples or food or drinks, were more likely to opt for
brand-name drugs vs. physicians who did not, the research
"The point is, industry marketing works," said study author Eric Campbell, a professor of medicine in the department of medicine at Harvard Medical School. "Despite the fact that controlling health care, and not wasting scarce resources, is a fundamental tenet of practicing medicine."
He said the added costs get passed on to everyone.
"The increased cost of prescribing non-generic drugs when generics are available are born by the patients in terms of higher co-pays and by society in the form of higher insurance premiums," Campbell noted.
"But, we found that 37 percent of doctors do this sometimes or often, despite the fact that the winners are always the drug companies and the losers are always the patients," he said.
"That figure, which is big already, is probably an underestimate," Campbell added, "because even though our survey was anonymous there's still going to be a reluctance among doctors to admit to doing something that would be perceived negatively."
The findings were reported online Jan. 7 in the journal
JAMA Internal Medicine.
According to the U.S. Food and Drug Administration, generic
drugs are "required to have the same active ingredient, strength,
dosage form and route of administration as the brand name."
FDA statistics suggest that about 80 percent of all drugs taken
in the United States are generic, and generics typically cost 80
percent less than their brand-name counterparts.
To better understand real-world prescribing behavior, the
researchers analyzed responses to a 2009 survey completed by about
1,900 physicians representing a variety of specialties.
On a positive note, the authors found that 63 percent of the
doctors polled said they never or rarely prescribe a brand-name
drug rather than a generic one solely on the basis of patient
However, nearly four in 10 doctors (37 percent) said that they
occasionally do prescribe a brand-name drug over its generic
counterpart, a statistic that represents roughly 286,000 physicians
across the United States.
The poll also revealed that when it comes to issuing brand-name
scripts, not all doctors are created equal. Certain specialties are
more prone to the practice than others, with prescription-heavy
internal medicine physicians being much more likely to acquiesce to
a patient's brand-name request than pediatricians, cardiologists,
general surgeons and/or anesthesiologists.
Physician age was a factor as well, with poll responses
indicating that among doctors in practice for three decades or
more, roughly four out of every ten (43 percent) gave in to
brand-name drug requests. This compared with just three in every
ten (31 percent) doctors with a decade or less of work
"Perhaps it's the case that older doctors were trained at a time when the cost of health care was not as salient an issue as it is today," Campbell added. "Or they may not see it as their personal responsibility, and want to give patients they have a long relationship with what they want. It all makes for a very big problem."
In addition, the survey also suggested that direct marketing,
from pharmaceutical companies to physicians, further tips the
scales in favor of brand-name scripts.
For example, nearly four in every ten physicians who were given
free food/drink by pharmaceutical firms said they honored patient
requests for brand-name drugs, compared with just a third of those
who did not receive such perks.
A nearly identical ratio (40 percent versus 31 percent) was
observed with respect to the prescribing behavior of doctors who
were given free drug samples versus those who were not. A similar
gap (40 percent versus 34 percent) was also found when comparing
docs who "sometimes or often" met with drug manufacturer reps
versus those who did not.
Steven Kayser, of the department of clinical pharmacy in the
school of pharmacy at the University of California, San Francisco,
argues that drug manufacturers have a huge financial incentive to
ensure that generics don't thrive.
"There is still significant influence from industry to use brand name drugs, and coupled with direct-to-consumer advertising, it is not surprising that patients become distrustful of using generic drugs," said Kayser, who is also the author of a journal editorial on the study. "There is a great deal that needs to be accomplished in educating both health professionals and patients about generics drugs in an effort to rein in the increasing cost of medications," he said.
For more on generic medications, visit
U.S. Food and Drug Administration.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.